Ayer Capital Management’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
$935K Hold
41,667
3.49% 2
2015
Q1
$407K Buy
+41,667
New +$407K 0.6% 2